Curidium Medica plc - Presentations at Conferences
London, UK, 20 May 2008, Curidium Medica plc, (LSE: CUR) the
personalized medicine company focused on bringing the right drug to the
right patient, today announced that Dr. Anne Bruinvels, Founder and
Chief Scientific Officer, will be presenting at the PharmaIQ's
Personalised Medicine 2008 in London on Thursday 22nd May at 14.00
local time at Cafe Royal, London.